LOW vs TSHA · P/E 18, rev $49.03B vs $640.7M cap
Lowe's Companies Inc (LOW) versus Taysha Gene Therapies Inc (TSHA) — a side-by-side from cached financials, not a winner call.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported LOW revenue for 2026-07-31 was $49.03B. Net income was $4.03B. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
LOW currently screens at market cap $121.89B and trailing P/E 18.4. TSHA currently screens at market cap $640.7M.
Not investment advice. Open the LOW and TSHA stock pages for the full models.
Not investment advice.